Wilson Sonsini Goodrich & Rosati represented Epic Cleantec in the transaction. Epic Cleantec (Epic), a leader in water reuse technology for the built environment, announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Soleno Therapeutics on the offering, and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. advised the underwriters. Soleno Therapeutics, Inc....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Orbillion in the transaction. Cultivated meat start-up Orbillion announced it has raised fresh capital that brings its cumulative funding to $15...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Amring Pharmaceuticals Inc. on the transaction, and Wilson Sonsini Goodrich & Rosati advised Visant Medical. Amring Pharmaceuticals Inc....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Cooley advised Soleno Therapeutics on the deal. Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno”) announced the pricing of the underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Respiratory Motion on the deal. Senzime completed the acquisition of 100 percent of the shares in Respiratory Motion, as was made public on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini represented Wildtype on the deal. Wildtype, a start-up creating sushi-grade cultivated salmon, announced the completion of a $100 million Series B funding round, the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Enable Injections on the deal. Enable Injections, Inc., a company developing and manufacturing the enFuse platform of investigational wearable drug...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Humane, Inc. on the deal. Humane, Inc. announced it has raised $100 million in its Series B round, which was...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Saranas on the deal, while Latham & Watkins represented Baird Capital. Houston, Texas-based Saranas announced a $12.8 million Series B...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Emboline on the deal. Emboline, Inc., a privately held medical device company focused on reducing stroke and other damage caused...
You must be a Standard 1 Year member to access this content.
